Argenx Se (ARGX) Net Margin (2016 - 2026)
Argenx Se (ARGX) posted Net Margin of 28.2% for Q1 2026, down 31.98% on a QoQ basis from 41.45% in Q4 2025, and up 680.0% year-over-year from 3.62% in Q1 2025.
Argenx Se (ARGX) Net Margin (2016 - 2026) Analysis & Trends
Argenx Se's Net Margin history runs 11 years deep, the most recent figure standing at 28.2% for Q1 2026.
- Quarterly Net Margin rose 680.0% year-over-year to 28.2% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 31.95% (down 932.0% YoY) and the FY2025 annual result came in at 31.12%, down 699.0% from the prior year.
- Net Margin was 28.2% for Q1 2026 at Argenx Se, down from 41.45% in the prior quarter.
- Across five years, Net Margin topped out at 886.14% in Q2 2022 and bottomed at 1073.51% in Q1 2022.
- A 5-year average of 13.32% and a median of 6.09% in 2024 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin sank 104794 bps — and 2023, when it surged 106026 bps.
- Argenx Se's Net Margin stood at 22.27% in 2022, then decreased by 19 bps to 26.49% in 2023, then soared by 497 bps to 105.05% in 2024, then plunged by 61 bps to 41.45% in 2025, then sank by 32 bps to 28.2% in 2026.
- Business Quant data shows ARGX's Net Margin at 28.2% in Q1 2026, 41.45% in Q4 2025, and 30.55% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 15.02% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 28.20% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 17.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.20% |
| Dec 31, 2025 | 41.45% |
| Sep 30, 2025 | 30.55% |
| Jun 30, 2025 | 25.87% |
| Mar 31, 2025 | 21.39% |
| Dec 31, 2024 | 105.05% |
| Sep 30, 2024 | 15.95% |
| Jun 30, 2024 | 6.09% |
| Mar 31, 2024 | -15.47% |
| Dec 31, 2023 | -26.49% |
| Sep 30, 2023 | -22.07% |
| Jun 30, 2023 | -35.04% |
| Mar 31, 2023 | -13.24% |
| Dec 31, 2022 | -22.27% |
| Sep 30, 2022 | -178.97% |
| Jun 30, 2022 | 886.14% |
| Mar 31, 2022 | -1,073.51% |
| Dec 31, 2021 | -913.91% |
| Sep 30, 2021 | -0.03% |
| Jun 30, 2021 | -164.36% |